These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

747 related articles for article (PubMed ID: 18649770)

  • 1. [Effects of valsartan, mycophenolate mofetil and their combined application on TRAIL and nuclear factor-kappaB expression in the kidneys of diabetic rats].
    Chen B; Zhang Y; Liu G; Guan GJ; Hou XH; Li XG; Liu JL
    Zhonghua Yi Xue Za Zhi; 2008 Feb; 88(8):540-5. PubMed ID: 18649770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of mycophenolate mofetil, valsartan and their combined therapy on preventing podocyte loss in early stage of diabetic nephropathy in rats.
    Zhang Y; Chen B; Hou XH; Guan GJ; Liu G; Liu HY; Li XG
    Chin Med J (Engl); 2007 Jun; 120(11):988-95. PubMed ID: 17624267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experimental study of leflunomide on renal protective effect and on inflammatory response of streptozotocin induced diabetic rats.
    Yu WM; Wang H; Ren XJ; Liu JP; Wang JY
    Nephrology (Carlton); 2012 May; 17(4):380-9. PubMed ID: 22243699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mycophenolate mofetil and valsartan inhibit podocyte apoptosis in streptozotocin-induced diabetic rats.
    Lv W; Zhang Y; Guan G; Li P; Wang J; Qi D
    Pharmacology; 2013; 92(3-4):227-34. PubMed ID: 24158161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of quercetin on nuclear factor-κB p65 expression in renal ubiquitin-proteasome system of diabetic rats].
    Chen P; Chen JB; Chen WY; Zheng QL; Wang YQ; Xu XJ
    Zhonghua Nei Ke Za Zhi; 2012 Jun; 51(6):460-5. PubMed ID: 22943758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Activation of transforming growth factor-beta1/Smads signal pathway in diabetic cardiomyopathy and effects of valsartan thereon: experiment with rats].
    Miao Y; Zhang W; Zhong M; Ma X; Qi TG; Sun H
    Zhonghua Yi Xue Za Zhi; 2007 Feb; 87(6):366-70. PubMed ID: 17456374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Mechanism of reversion of myocardial interstitial fibrosis in diabetic cardiomyopathy by valsartan].
    Zhong M; Zhang Y; Miao Y; Li L; Gong HP; Ma X; Sun H; Zhang W
    Zhonghua Yi Xue Za Zhi; 2006 Jan; 86(4):232-6. PubMed ID: 16677501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renoprotective effects of valsartan and enalapril in STZ-induced diabetes in rats.
    Kalender B; Oztürk M; Tunçdemir M; Uysal O; Dagistanli FK; Yegenaga I; Erek E
    Acta Histochem; 2002; 104(2):123-30. PubMed ID: 12086332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Valsartan inhibited HIF-1α pathway and attenuated renal interstitial fibrosis in streptozotocin-diabetic rats.
    Tang L; Yi R; Yang B; Li H; Chen H; Liu Z
    Diabetes Res Clin Pract; 2012 Jul; 97(1):125-31. PubMed ID: 22377232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Relationship between activation of mannan-binding lectin complement and NF-kappaB in diabetic nephropathy].
    Yang YX; Huang SM; Yan XY; Wu WH
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2011 Jul; 42(4):490-3. PubMed ID: 21866632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Protective effect of astragalus saponin extracts on kidneys of diabetic rats].
    Xiao F; Hu YG; Wu SN; Shou QY; Cai YQ; Wang HM; Wang H
    Zhongguo Zhong Yao Za Zhi; 2015 May; 40(10):2014-8. PubMed ID: 26390666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BAY 11-7082 ameliorates diabetic nephropathy by attenuating hyperglycemia-mediated oxidative stress and renal inflammation via NF-κB pathway.
    Kolati SR; Kasala ER; Bodduluru LN; Mahareddy JR; Uppulapu SK; Gogoi R; Barua CC; Lahkar M
    Environ Toxicol Pharmacol; 2015 Mar; 39(2):690-9. PubMed ID: 25704036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Impact of glycogen synthase kinase-3β (GSK-3β) inhibitor on Wnt and NF-κB signal pathways in a rat model of diabetic nephropathy].
    Zhou Y; Li L; Yu Y; Yang H; Yao H; Zhang Y; Zhang L; Deng C; Zhao L; Zhang Y; Song B
    Zhonghua Bing Li Xue Za Zhi; 2015 Nov; 44(11):783-7. PubMed ID: 26888388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Local delivery of angiotensin II receptor blockers into the kidney passively attenuates inflammatory reactions during the early phases of streptozotocin-induced diabetic nephropathy through inhibition of calpain activity.
    Kamal F; Yanakieva-Georgieva N; Piao H; Morioka T; Oite T
    Nephron Exp Nephrol; 2010; 115(3):e69-79. PubMed ID: 20424485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mycophenolate mofetil ameliorates diabetic nephropathy through epithelial mesenchymal transition in rats.
    Xiao X; Wang J; Chang X; Zhen J; Zhou G; Hu Z
    Mol Med Rep; 2015 Sep; 12(3):4043-4050. PubMed ID: 26080907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Irbesartan ameliorates diabetic nephropathy by reducing the expression of connective tissue growth factor and alpha-smooth-muscle actin in the tubulointerstitium of diabetic rats.
    Ren X; Guan G; Liu G; Liu G
    Pharmacology; 2009; 83(2):80-7. PubMed ID: 19065061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined MMF and insulin therapy prevents renal injury in experimental diabetic rats.
    Wu X; Zha D; Xiang G; Zhang B; Xiao SY; Jia R
    Cytokine; 2006 Dec; 36(5-6):229-36. PubMed ID: 17337203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of lovastatin on renal function and expression of phosphorylating-p38 mitogen-activated protein kinase in experimental diabetic nephropathy in rats].
    Wang LH; Duan HJ; Shi YH; Liu QJ; He N; Liu SX
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2004 Dec; 16(12):734-7. PubMed ID: 15585148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of leflunomide and benazepril reduces renal injury of diabetic nephropathy rats and inhibits high-glucose induced cell apoptosis through regulation of NF-κB, TGF-β and TRPC6.
    Li H; Wang Y; Zhou Z; Tian F; Yang H; Yan J
    Ren Fail; 2019 Nov; 41(1):899-906. PubMed ID: 31552773
    [No Abstract]   [Full Text] [Related]  

  • 20. Prevention of early renal injury by mycophenolate mofetil and its mechanism in experimental diabetes.
    Wu YG; Lin H; Qi XM; Wu GZ; Qian H; Zhao M; Shen JJ; Lin ST
    Int Immunopharmacol; 2006 Mar; 6(3):445-53. PubMed ID: 16428080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.